In tissue cultures of normal adult and malignant mammalian cells, homocystine has been substituted for methionine in a medium rich in folic acid and cyanocobalamin. Normal adult cells thrive. Three highly malignant cell types from three different species, including man, die.
A metabolic defect seen to date only in cancer cells was uncovered during an investigation of transfer RNA methylation using tissue cultures of normal adult and malignant cells (1, 2) . In several lines of malignant cells we have observed an inability of the cells to survive and grow when methionine is replaced in the medium with homocystine. However, normal adult cell lines derived from mice, rats, and humans survive and grow well with this substitution. The apparent absolute dependence of the malignant cells on preformed methionine is of considerable theoretical interest but may also be of practical importance because it may offer another avenue for treating neoplastic disease.
An earlier study (3) , confirmed in our laboratory, has clearly indicated that dietary depletion of methionine has an inhibitory effect on the growth of Walker-256 carcinosarcoma. We became interested in this problem through our studies on methylation of transfer RNA in Walker-256 cells, and the present work demonstrates the dependence of this and other malignant cell lines on preformed methionine. In contrast to the malignant cell lines, we show that a number of normal adult cell lines can satisfy their methionine requirements with homocystine in a folic acid-, cyanocobalamin-rich medium.
METHODS
Tissue cultures of Walker-256 (W-256), breast carcinosarcoma of rats; L1210, lymphatic leukemia of mice; J111, monocytic leukemia of humans; as well as liver epithelial and liver fibroblasts of rats, skin fibroblasts of mice, and fibroblasts from human breast and prostate (all concurrently PPLO negative) were grown in a commercially available, specifically modified McCoy's medium. The composition of the medium was routinely checked by amino-acid analysis before use. It was devoid of bactopeptone but reinforced with 15% fetal-calf serum that had been dialyzed for 24 hr at 40 against three changes of a solution containing 8 g of NaCl, 0.4 g of KCl, 1 g of glucose, and 0.35 g of NHCO3 per liter. In addition, the medium contained trace metals (10 (Fig. 2) , and on human monocytic leukemia cells (J111) (Fig. 3) . Substitution of homocystine for methionine produces little alteration in the growth rates of normal adult epithelial and fibroblastic cells. This is clearly evident in the growth curves of rat-liver fibroblasts ( In additional experiments we varied the concentration of methionine in the medium in order to assess the absolute dependence for growth on this amino acid. As the concentration of methionine was reduced stepwise, a marked reduction in the growth rate of the W-256 cells was observed (Fig. 7) (6, 7, 9) . The maximal effect in vivo was achieved by a vitamin B12 (hydroxycobalamin) concentration of 0.5 mg/liter (6) ; however, mammalian cells grow well in media lacking vitamin B12 but not without methionine (10) .
Reducing the concentration of methionine in the presence of homocysteine in the tissue cultures of baby hamster kidney (BHK) cells induces increased synthesis of the tetrahydrofolate methyltransferase (8) . Maximal growth rate of BHK cells in methionihe-deficient medium containing homocysteine and vitamin B12 is achieved by increasing the folic-acid concentration to 0.1 mM (44 mg/liter) (8) .
Two tissue culture cell lines derived from human cancers, HEp-2 and HeLa, apparently thrived on a medium without added methionine and choline but containing homocysteine (0.1 mM), 10% undialyzed fetal-calf serum, folic acid (1 mg/liter), and hydroxycobalamin (0.5 mg/liter) (6). However, in tissue culture media lacking methionine but containing vitamin B12 and folic acid, the addition of homocysteine proved inadequate for the growth of L 5178 Y mouse leukemia cells (11) .
The dietary requirement of the whole animal (chickens and rats) for methionine can be achieved by feeding homocystine plus either choline or vitamin supplements-specifically vitamin B12 and folic acid (12) (13) (14) (15) The formation of methionine occurs in the tissues of the rat and not in the gut, but requires both folic acid and vitamin B12 (i6). Moreover the enzyme, 5-methyltetrahydrofolate: homocysteine methyltransferase has been found in all normal adult rat tissues except the small intestine (17) . It has also been found in biopsies of normal liver and kidney and cultures of human skin fibroblasts (7, 18, 19) .
We have shown, as have others (5, 6, 8, 9) , that normal adult mammalian cells can utilize homocystine in place of methionine in tissue culture when the medium contains folic acid (5-10 mg/liter) and vitamin B12 (2-4 mg/liter). We also demonstrated that a rat breast carcinosarcoma (W-256), a mouse leukemia (L1210), and a human monocytic leukemia cannot utilize homocystine for growth even when supplemented with high levels of folic acid and vitamin B12. In the medium containing cyanocobalamin (2 mg/liter) and folic acid (10 mg/liter) W-256 cells continue to grow when the methionine concentration is reduced from the usual 0.1 mM to 0.01 mM. In order to obtain a cessation of growth, one must reduce the methionine concentration to below 0.002 mM (Fig.  7) . To achieve this concentration of methionine in the tissue culture medium, the added fetal-calf serum must be dialyzed.
It is unlikely that all cancers have as complete a metabolic defect as those reported here, but we have used conditions that produce optimal synthesis and activity of the homocysteine methylating enzyme. The concentration of vitamin B12 in our media was 2000-4000 pg/liter, whereas the concentration in normal human se um is 0.2-0.9 pg/liter (20) . Similarly, the concentration of folic acid in the medium was 5000-10,000 ptg/liter, whereas the concentration in human serum is [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] psg/liter (20) . It is possible that many tumors may be more susceptible to methionine deprivation at serum levels of vitamin B12 and folic acid.
Throughout all experiments, all neoplastic cell lines remained highly malignant. This was demonstrated by frequent injections of tissue culture cells (105 W-256 and L1210) into the animals of origin. The human monocytic leukemia was also malignant. In order to treat an animal with a malignant tumor, the supply of methionine to the cancer cell must be drastically curtailed. If one applies the results obtained from tissue cultures of W-256 cells, the serum concentration of methionine (normally 0.1 mM) must be reduced more than 50-fold. As previously shown, effective control of tumor growth could not be accomplished by a diet devoid of methionine (3) and, in our own case, by a diet devoid of cystine as well. The eradication of neoplastic cells by methionine deprivation requires a means of destroying or removing the continuously replenished methionine in the serum. This can be accomplished by the enzymatic destruction of the methionine in the serum. Methioninase, an enzyme found in a Pudomonas species (21) and in Clostridium sporogenes (22) has already been shown to dethiomethylate and deaminate methionine in vivo (23) .
The pivotal position of methionine in mammalian metabolism of protein, folic acid, and vitamin B12 (24, 25) , particularly when any of the latter three are in insufficient supply, has directed some of our present investigations to the use of methioninase in tissue cultures of normal cells, and in healthy animals that are supplied with nutrients lacking methionine and cystine but fortified with homocystine, vitamin B12 and folic acid. Because it is theoretically possible to nourish every normal cell by supplying homocystine while depleting the neoplastic cells of methionine, we are also treating tumorbearing animals to determine whether this particular biochemical difference between normal and malignant cells can be exploited therapeutically. 
